卡培他滨联合放疗对进展期直肠癌的治疗价值评析被引量：3

导出

摘要目的对卡培他滨联合放疗进展期直肠癌的临床价值研究。方法选取2014年6月至2015年6月我院收治的进展期直肠癌患者100例,根据治疗方式分为对照组和联合组,分别采取单纯放疗及卡培他滨联合放疗治疗,后比较两组患者临床治疗效果。结果联合组进展期直肠癌患者临床总有效率96.00%显著高于对照组74.00%,P<0.05。结论给予进展期直肠癌患者卡培他滨联合放疗治疗能有效改善患者的临床疗效。

作者高东

机构地区辽宁省鞍山市肿瘤医院

出处《中国医药指南》 2016年第31期69-69,共1页 Guide of China Medicine

关键词卡培他滨放疗进展期直肠癌

分类号 R735.37 [医药卫生—肿瘤]

引文网络
相关文献

参考文献2

1帖晓静,田永巍,高岭,李宁,刘培杰,徐志巧.卡培他滨联合放疗治疗局部进展期直肠癌的疗效观察[J].中国全科医学,2013,16(11):1301-1303. 被引量：18
2肖林,黄蓉,游凯云,常晖,邱波,肖巍魏,陈利,高远红,刘孟忠.容积调强弧形放疗联合Xelox化疗方案应用于局部进展期直肠癌新辅助治疗的可行性研究[J].中华胃肠外科杂志,2014,17(3):219-224. 被引量：14

二级参考文献41

1吾甫尔·艾克木,王若峥,王多明.卡培他滨化疗同步放射治疗局部晚期直肠癌的疗效观察[J].中国全科医学,2009,12(15):1426-1427. 被引量：9
2蔡钢,章真.直肠癌的辅助放化疗的临床研究[J].中国癌症杂志,2006,16(5):399-402. 被引量：13
3Sebag - Montefiore D, Stephens R J, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer ( MRC CR07 and NCIC - CTG C016) : a multicentre, random- ised trial [ J ]. Lancet, 2009, 373 (9666) : 811 -820.
4Chert CF, Huang MY, Huang C J, et al. A observational study of the efficacy and safety of capecitabine versus bolus infusional 5 - flu- omuracil in pre - operative chemoradiotherapy for locally advanced rectal cancer [ J]. Int J Colorectal Dis, 2012, 27 (6): 727-736.
5Hoiheinz RD, Wenz F, Post S, et al. Che- moradiotherapy with capecitabine versus flu- orouracil for locally advanced rectal cancer: arandomised, muhicentre, non - inferiority, phase 3 trial [J]. Lancet Oncol, 2012, 13 (6) : 579 -588.
6Sun PL, Li B, Ye QF. Effect of neoadjuvant cetuximab, capeeitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study [ J]. Int J Colorectal Dis, 2012. 27 C10) : 1325 - 1332.
7Rullier E, Goffre B, Bonnel C, et al. Pre- operative radiochemotherapy and sphincter- saving resection for T3 carcinomas of the lower third of the rectum [J]. Ann Surg, 2001, 234 (5) : 633 - 640.
8Tarantino I, Warschkow R, Worni M. Ele- vated preoperative CEA is associated with worse survival in stage I - 111 rectal cancer patients [ J ]. Br J Cancer, 2012, 107 (2) : 266 - 274.
9Kim CW, Yu CS, Yang SS, et al. Clinical significance of pre - to post - chemoradiother- apy s - CEA reduction ratio in rectal cancer patients treated with preoperative chemoradio- therapy and curative resection [ J ]. Ann Surg Oncol, 2011, 18 (12): 3271 - 3277.
10Garajov6 I, Di Girolamo S, de Rosa F, et al. Neoadjuvant treatment in rectal cancer: actual status [J]. Chemother Res Pract, 2011,2011 : 839742.